The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000707369p
Ethics application status
Help: Ethics application status
Not yet submitted
Date submitted
Help: Date submitted
25/05/2026
Date registered
Help: Date registered
12/06/2026
Date last updated
Help: Date last updated
12/06/2026
Date data sharing statement initially provided
Help: Data sharing statement date
12/06/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
The CIRCA DIEM KIDS Study: Assessment of developmental and health outcomes at 5-8 years of children born preterm who were participants in the CIRCA DIEM study of cycled light and noise as babies.
Scientific title
Cognitive and sensory functioning at 5-8 years in children born preterm who were participants in the CIRCA DIEM randomised controlled trial of cycled light and noise as babies.
Additional trial identifiers [1] 317060 0
Nil
Universal Trial Number (UTN)
Trial acronym
CIRCA DIEM KIDS
Related trial records
ACTRN12618000371291 is the parent study for the follow-up study described in this record.

Health condition
Health condition(s) studied:
Prematurity 341578 0
Neurodevelopment 342190 0
Sensory processing ability 342195 0
Sleep disturbances 342199 0
Circadian rhythmicity 342200 0
Condition category
Condition code
Neurological 337647 337647 0 0
Other neurological disorders
Reproductive Health and Childbirth 338320 338320 0 0
Complications of newborn

Intervention/exposure
Study type
Observational
Patient registry
False
Target follow-up duration
Target follow-up type
Description of the intervention or exposure
Infants were randomised to either cycled light and noise or to routine non-cycled environmental care during the initial hospitalisation after preterm birth as participants in the parent CIRCA DIEM Study (ACTRN12618000371291).
The CIRCA DIEM KIDS study will follow the CIRCA DIEM participant cohort as they reach 5-8 years of age to assess their neurodevelopment, growth, and general wellbeing including sleep and chronotype.
Parents or caregivers of study participants will be asked to bring their child to a core clinical assessment for general well being (approximately 1 hour) by a research nurse or physician, as well to have a developmental assessment (Weschler Preschool and Primary Scale of Intelligence - WPPSI; approximately 1.5-2 hours) to assess intelligence, performed by appropriately qualified staff (psychologist, medical practictioner, child therapist). Assessments will be undertaken at clinical assessment centres.
Parents will also be asked to complete questionnaires relating to their child's behaviour, sleep patterns, quality of life, and general development and well-being.

Additionally, participants will be asked to be involved in one or more CIRCA DIEM KIDS Substudies (to be described under additional linked ANZCTRN) to assess vision, hearing, and respiratory function, and to quantify sleep using actigraphy. Some children will also be enrolled in a biological substudy to contribute biological samples (blood, saliva, buccal swabs, nasal lining fluid, nasal brushings, urine and faeces) to investigate immune, microbiological, circadian and respiratory biology after early exposure to cycled light and noise.
Intervention code [1] 333816 0
Not applicable
Description of the comparator or control
The comparator group are the participants randomised or allocated to receive routine non-cycled environmental care during initial hospitalisation after preterm birth as part of the parent CIRCA DIEM Study (ACTRN12618000371291). Children in the comparator group will undergo the same assessments as described above for the group exposed to cycled light and noise in the parent CIRCA DIEM Study (ACTRN12618000371291).
Control group
Active

Outcomes
Primary outcome [1] 345137 0
Full scale intelligence quotient
Timepoint [1] 345137 0
6 years (60-95 months)
Secondary outcome [1] 461948 0
Verbal comprehension index (VCI)
Timepoint [1] 461948 0
6 years (60-95 months)
Secondary outcome [2] 461949 0
Visual Spatial Index (VSI)
Timepoint [2] 461949 0
6 years (60-95 months)
Secondary outcome [3] 461950 0
Fluid Reasoning Index (FRI)
Timepoint [3] 461950 0
6 years (60-95 months)
Secondary outcome [4] 461951 0
Working Memory Index (WMI)
Timepoint [4] 461951 0
6 years (60-95 months)
Secondary outcome [5] 461952 0
Processing Speed Index (PSI)
Timepoint [5] 461952 0
6 years (60-95 months)
Secondary outcome [6] 461953 0
Prevalence of a diagnosis of ASD
Timepoint [6] 461953 0
6 years (60-95 months)
Secondary outcome [7] 461954 0
Height
Timepoint [7] 461954 0
6 years (60-95 months)
Secondary outcome [8] 461955 0
Weight (mass)
Timepoint [8] 461955 0
6 years (60-95 months)
Secondary outcome [9] 461956 0
Fat free mass index (FFMI)
Timepoint [9] 461956 0
6 years (60-95 months)
Secondary outcome [10] 461957 0
Waist girth to height ratio
Timepoint [10] 461957 0
6 years (60-95 months
Secondary outcome [11] 461958 0
Blood pressure
Timepoint [11] 461958 0
6 years (60-95 months)
Secondary outcome [12] 461959 0
Average total sleep time (TST)
Timepoint [12] 461959 0
6 years (60-95 months)
Secondary outcome [13] 461960 0
Average Sleep Efficiency (SE) Index
Timepoint [13] 461960 0
6 years (60-95 months)
Secondary outcome [14] 461961 0
Average sleep onset latency (SOL)
Timepoint [14] 461961 0
6 years (60-95 months)
Secondary outcome [15] 461962 0
Average wake after sleep onsent (WASO) measured as the total time spent awake after initially falling asleep
Timepoint [15] 461962 0
6 years (60-95 days)
Secondary outcome [16] 461963 0
Average heart rate variability (HRV)
Timepoint [16] 461963 0
6 years (60-95 months)
Secondary outcome [17] 461964 0
Average midsleep point on free days
Timepoint [17] 461964 0
6 years (60-95 months)

Eligibility
Key inclusion criteria
• Participant in the parent CIRCA DIEM Study (ACTRN12618000371291)
• Informed parental/guardian consent
• Age at least 5 years postnatal age (PNA): (range 60 to 95 months)
• Survival to 5 years chronological age
Minimum age
5 Years
Maximum age
8 Years
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
• Parents/guardians previously indicated non-willingness to be contacted for future research projects related to The CIRCA DIEM Study. (ACTRN12618000371291).
• Post-discharge survival to 5 years (or date of initial recruitment contact – whichever is the later) not confirmed or known death.

Study design
Purpose
Natural history
Duration
Longitudinal
Selection
Timing
Both
Statistical methods / analysis
Data will be analysed in R (open-source) on an intention-to-treat basis by the trial biostatistician, blinded to study group assignment.
Missing data will be handled via multiple imputation or appropriate methods detailed in the statistical analysis plan (SAP). Children unable to be tested on WPPSI-IV due to death, disability, severe delay, or performance below the threshold for individual composite scores will be assigned a low score for the primary analysis, which is based on ranks, and alternative methods are employed for secondary estimands and sensitivity analyses, as detailed in the SAP.
Comparability of study groups at baseline will be based on summaries of patient demographic data (birth weight Z-score, sex, gestation, exposure to chorioamnionitis and maternal steroids). Descriptive statistics will include mean (SD), median (IQR) for continuous variables with symmetric and asymmetric distributions, respectively, and counts/percentages for categorical variables.
Primary analysis: Full-scale intellectual quotient (FSIQ) scores will be compared between the two intervention groups at 78 (60-95) months chronological age (primary outcome) using the Wilcoxon rank sum test and summarised using the Hodges-Lehmann estimator of location to estimate the median of differences, with an asymptotic 95% confidence interval.
Secondary analyses: Cognitive scores (primary outcome) will also be compared between the two study groups (intervention and control) using linear mixed effects regression, with partial clustering for multiple births, adjusted for socioeconomic status, parental risk index, sex, birthweight Z score, gestation age, antenatal and postnatal steroid use, key neonatal morbidity count and site.
All continuous secondary outcomes will be analysed using either the Wilcoxon rank sum test or linear mixed effects regression, depending on the estimand defined in the SAP; these analyses treat post-randomisation events differently and thus answer different research questions. Mixed models will be used for visual outcomes to account for both eyes. All binary secondary outcomes will be analysed using logistic regression, adjusting for the covariates listed above. The false discovery rate for all secondary analyses will be calculated using the Benjamini-Hochberg algorithm.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
NSW,QLD,SA,WA,VIC
Recruitment outside Australia
Country [1] 28145 0
New Zealand
State/province [1] 28145 0

Funding & Sponsors
Funding source category [1] 320640 0
Government body
Name [1] 320640 0
West Australian Child Research Fund
Country [1] 320640 0
Australia
Funding source category [2] 321948 0
Charities/Societies/Foundations
Name [2] 321948 0
Stan Perron Charitable Research Foundation
Country [2] 321948 0
Australia
Primary sponsor type
Charities/Societies/Foundations
Name
The Kids Research Institute Australia
Address
Country
Australia
Secondary sponsor category [1] 324819 0
None
Name [1] 324819 0
Address [1] 324819 0
Country [1] 324819 0

Ethics approval
Ethics application status
Not yet submitted
Ethics committee name [1] 319182 0
WA Health Central HREC
Ethics committee address [1] 319182 0
Ethics committee country [1] 319182 0
Australia
Date submitted for ethics approval [1] 319182 0
20/06/2026
Approval date [1] 319182 0
Ethics approval number [1] 319182 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 146518 0
Prof Prof Jane Pillow
Address 146518 0
The Kids Research Institute Australia, 15 Hospital Ave, Nedlands, Western Australia, 6009
Country 146518 0
Australia
Phone 146518 0
+61 4 17621960
Fax 146518 0
Email 146518 0
Contact person for public queries
Name 146519 0
Prof Jane Pillow
Address 146519 0
The Kids Research Institute Australia, 15 Hospital Ave, Nedlands, Western Australia, 6009
Country 146519 0
Australia
Phone 146519 0
+61 4 17621960
Fax 146519 0
Email 146519 0
Contact person for scientific queries
Name 146520 0
Prof Jane Pillow
Address 146520 0
The Kids Research Institute Australia, 15 Hospital Ave, Nedlands, Western Australia, 6009
Country 146520 0
Australia
Phone 146520 0
+610417621960
Fax 146520 0
Email 146520 0

Data sharing statement
Will the study consider sharing individual participant data?
Yes
Will there be any conditions when requesting access to individual participant data?
Persons/groups eligible to request access:
• Researchers
Conditions for requesting access:
• Yes, conditions apply:
• Requires review on a case-by-case basis by the trial custodian, sponsor or data sharing committee
• Requires a scientifically sound proposal or protocol
• Requires approval by an ethics committee
• Requires a data sharing agreement between data requester and trial custodian or sponsor
What individual participant data might be shared?
• De-identified individual participant data:
• Published results
• Primary outcome(s)
What types of analyses could be done with individual participant data?
• Systematic reviews and meta-analyses
• Studies testing whether findings can be repeated or confirmed
When can requests for individual participant data be made (start and end dates)?
From:
After publication of main results
To:
Not yet decided
Where can requests to access individual participant data be made, or data be obtained directly?
• Email of trial custodian, sponsor or committee: [email protected]

Are there extra considerations when requesting access to individual participant data?
Yes: Individual participant data will not be possible for data obtained by data linkage, as these data are deterministic and unable to be linked to known individual data.



What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.